<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Griffeth EM</submitter><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>499-507</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10524729</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>116(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Little data exist regarding characteristics and outcomes of pediatric patients undergoing septal myectomy. We evaluated this in a large referral population.&lt;h4>Methods&lt;/h4>Septal myectomy was performed in 199 consecutive patients aged ≤18 years with obstructive hypertrophic cardiomyopathy from January 1, 1976, to June 30, 2021.&lt;h4>Results&lt;/h4>Median age was 13 years (interquartile range [IQR], 8-15 years). Left ventricular myectomy approaches included transaortic (163 of 198 [82%]), transapical (16 of 198 [8%]), and combined (19 of 198 [10%]). Right ventricular interventions included myectomy (13 of 199 [7%]) and patch reconstruction of the outflow tract (15 of 199 [8%]). Maximum left ventricular outflow tract gradients decreased after myectomy (prebypass: 50 mm Hg [IQR,</pubmed_abstract><journal>The Annals of thoracic surgery</journal><pubmed_title>Septal Myectomy Outcomes in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy.</pubmed_title><pmcid>PMC10524729</pmcid><funding_grant_id>R38HL150086</funding_grant_id><funding_grant_id>R38 HL150086</funding_grant_id><pubmed_authors>Ackerman MJ</pubmed_authors><pubmed_authors>Stephens EH</pubmed_authors><pubmed_authors>Alzate-Aguirre M</pubmed_authors><pubmed_authors>Dearani JA</pubmed_authors><pubmed_authors>Johnson JN</pubmed_authors><pubmed_authors>Wackel PL</pubmed_authors><pubmed_authors>Cannon BC</pubmed_authors><pubmed_authors>Schaff HV</pubmed_authors><pubmed_authors>Bos JM</pubmed_authors><pubmed_authors>Todd A</pubmed_authors><pubmed_authors>Griffeth EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Septal Myectomy Outcomes in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy.</name><description>&lt;h4>Background&lt;/h4>Little data exist regarding characteristics and outcomes of pediatric patients undergoing septal myectomy. We evaluated this in a large referral population.&lt;h4>Methods&lt;/h4>Septal myectomy was performed in 199 consecutive patients aged ≤18 years with obstructive hypertrophic cardiomyopathy from January 1, 1976, to June 30, 2021.&lt;h4>Results&lt;/h4>Median age was 13 years (interquartile range [IQR], 8-15 years). Left ventricular myectomy approaches included transaortic (163 of 198 [82%]), transapical (16 of 198 [8%]), and combined (19 of 198 [10%]). Right ventricular interventions included myectomy (13 of 199 [7%]) and patch reconstruction of the outflow tract (15 of 199 [8%]). Maximum left ventricular outflow tract gradients decreased after myectomy (prebypass: 50 mm Hg [IQR,</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2025-04-19T01:42:49.943Z</modification><creation>2025-04-07T12:26:10.15Z</creation></dates><accession>S-EPMC10524729</accession><cross_references><pubmed>37116851</pubmed><doi>10.1016/j.athoracsur.2023.04.021</doi></cross_references></HashMap>